Conversations in Drug Development Trends

MARCH 7, 2024

When conducting first-in-human (FIH) clinical trials, small to midsize pharmaceutical and biotechnology companies are faced with several crucial choices that can shape the trajectory of their drug development pathway. For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials 52

Clinical Trials Trials FDA Drug Development 52

Conversations in Drug Development Trends

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs. The Advantages of Midsize CROs In contrast to large CROs, midsize CROs like Worldwide Clinical Trials offer a unique value proposition to the market.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies 52

Perficient: Drug Development

FEBRUARY 14, 2024

Revolutionizing B2C Commerce: The Impact of Generative AI In the dynamic landscape of commerce and consumer-driven markets, Business-to-Consumer (B2C) organizations are increasingly turning to generative AI to revolutionize their operations and enhance customer experiences.

Marketing 115

Marketing International Research Production 115

The Pharma Data

SEPTEMBER 9, 2020

Download Your Copy. We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Download Your Copy. You have the right to object.

Production 52

Production Laboratories Compliance Government 52

Perficient: Drug Development

SEPTEMBER 4, 2024

In June 2024, Oracle announced fiscal 2024 Q4 and full year financial results revealing the market demand for Oracle Cloud Applications remains strong with Oracle Q4 Cloud Application (SaaS) revenue up 10% and Q4 Fusion Cloud ERP (SaaS) revenue up 14%.

Production 52

Production Marketing 52

PPD

OCTOBER 2, 2024

To support these functions, PPD™ Functional Service Partnership (FSP) Clinical Operations solutions harness the full range of innovative technologies, applying extensive skill and expertise to empower our customers to bring therapies to market quickly and within budget.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Trials 52

Perficient: Drug Development

AUGUST 2, 2024

Product Operating Model: We focus on developing robust product operating models that align with our clients’ business objectives, ensuring sustainable growth and innovation. Perficient’s Expertise and Industry Focus Forrester based its analysis of service providers on two factors: market presence and services functionality.

Production 105

Production International Marketing Science 105

Perficient: Drug Development

NOVEMBER 22, 2023

Here, you can set specific values for download/upload speeds, and latency, and even simulate offline conditions. Customizing Network Conditions Download Speed: Change the download speed to imitate various network speeds. Upload Speed: Like adjusting the download speed, you can also modify the upload speed.

Marketing 52

Marketing 52

The Pharma Data

DECEMBER 15, 2020

The project also seeks to engage the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to identify opportunities for regulatory endorsement of such drug development tools. The Diamyd Medical data includes relevant information about disease progression, drug effects and clinical trial design.

Drug Development 40

Drug Development Clinical Trials Trials Vaccine 40

Perficient: Drug Development

AUGUST 22, 2023

According to Gartner’s Marketing Guide for Digital Health Platforms , over the past two years, the DHP market matured, “accelerated by healthcare provider demand for new capabilities to support a more efficient and integrated operating model for clinical service delivery.”

Science 98

Science Marketing Production 98

Perficient: Drug Development

JUNE 12, 2024

To install Ollama on your PC, you will first need to download the installer from the official Ollama website ( [link] ). Navigate to the download section and locate the version of Ollama compatible with your operating system.

Production 52

Production Licensing Licensing Research 52

Perficient: Drug Development

FEBRUARY 5, 2024

Market Appeal Products and services that embody Equitable Use principles appeal to a broader market. Inclusive designs attract a diverse consumer base, leading to increased market share, customer loyalty, and economic growth.

Production 52

Production Compliance Marketing Regulations 52

Perficient: Drug Development

AUGUST 4, 2023

The report offers an in-depth overview of 38 digital transformation service providers, offering valuable insights into the market landscape. Download the Forrester report, The Digital Transformation Services Landscape, Q3 2023 to find out more.

Marketing 98

Marketing Research Production 98

Perficient: Drug Development

JULY 19, 2024

According to Forrester, “To thrive in fragmented and restless markets, manufacturers must compete on economies of scope, sharing fixed costs between multiple product or asset variants to deliver the innovation, choice, and personalization that will win, serve, and retain customers.”

Production 64

Production Research Marketing 64

Perficient: Drug Development

FEBRUARY 28, 2024

With new risks, shifting market dynamics, and the unstoppable march of technology, the insurance industry finds itself at a crossroads. Artificial intelligence (AI) emerges as a pivotal force within the insurance industry, especially for regional carriers seeking to thrive in a competitive and dynamic market.

Production 59

Production Marketing 59

Perficient: Drug Development

AUGUST 7, 2023

We are excited to introduce a revolutionary visual modeling tool that empowers marketers to effortlessly design and implement personalized customer journeys, without the need for extensive programming knowledge. Easily define stages and actions to construct the decision-making process that aligns with your marketing goals.

Marketing 52

Marketing 52

Perficient: Drug Development

MAY 16, 2024

Accessible design expands market reach, enhances customer satisfaction, and fosters brand loyalty. Expanding Reach and Market Potential Accessible design opens up opportunities to reach previously underserved markets and demographics. GAAD is a reminder that together, we can create a more inclusive and accessible world for all.

Production 52

Production Marketing Compliance Engineering 52

Perficient: Drug Development

JULY 23, 2023

User-Friendly Documentation: The API documentation is well-documented and user-friendly, empowering developers to quickly understand and utilize the available endpoints. This ease of use allows for faster development cycles, reducing time-to-market for new features and enhancements, ultimately benefiting both businesses and customers.

Marketing 52

Marketing Production 52

Perficient: Drug Development

JANUARY 5, 2024

Organizations rely on continuous automation and testing (CAT) services to build business applications faster, with higher quality, and at scale to meet increasing market demands. Software is at the core of the modern business model, making quality and performance top priorities to stay competitive.

Engineering 64

Engineering Government International Production 64

Perficient: Drug Development

NOVEMBER 26, 2023

Screen readers, speech recognition, and accessible interfaces enhance the accessibility of online job portals, empowering individuals to navigate the job market independently. Remote Work Accessibility The rise of remote work has been a game-changer for many individuals with disabilities.

Production 52

Production Marketing 52

Perficient: Drug Development

JULY 11, 2023

The research firm asked each provider a set of in-depth questions to develop the report, which according to Forrester, leaders can “use to understand the value they can expect from a commerce services provider, learn how providers differ, and investigate options based on size and market focus,” as well as “explore potential partners.”

Marketing 40

Marketing Pharmaceuticals Production Research 40

Perficient: Drug Development

NOVEMBER 1, 2023

The report offers an overview of application modernization and migration services providers and provides valuable insights into the market landscape. The core business scenarios for this market have been identified by Forrester as cloud migration, application modernization, and data modernization.

Government 52

Government International Marketing Research 52

Perficient: Drug Development

JUNE 15, 2023

New test automation technologies are entering the market as the scope expands. The market was previously dominated by proprietary tools like selenium. However, new open-source tools are now leading the market. Playwright is one of many Test Automation Frameworks available in the market. What is Playwright? Forks: 2.8K

Marketing 52

Marketing Licensing Licensing Engineering 52

Perficient: Drug Development

MARCH 15, 2024

Forrester highlights cloud transformation as a key example, explaining that “Migration to the cloud continues to dominate the enterprise applications roadmap for large companies that want to scale their operations and decision-making in order to win, serve, and retain customers in more transparent and competitive markets.”

Government 59

Government Compliance International Marketing 59

Perficient: Drug Development

JANUARY 20, 2024

Equitable Use forms the bedrock of Universal Design, emphasizing the creation of products and environments that are useful and marketable to people with diverse abilities. Understanding Equitable Use What is Equitable Use in Universal Design?

Production 52

Production Marketing Research 52

The Pharma Data

JANUARY 13, 2021

14, 2021 /PRNewswire/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced the addition of Robert Barrow , an accomplished pharmaceutical executive, as Chief Development Officer. We are excited to attract such top tier talent from the psychedelic drug development community.

Clinical Trials 52

Clinical Trials FDA Trials Production 52

Perficient: Drug Development

JANUARY 16, 2024

These principles, originally developed by a team of architects, product designers, engineers, and environmental design researchers led by Ronald Mace at North Carolina State University, provide a comprehensive framework for designing with diversity in mind. Let’s explore each of the seven principles: 1.

Production 52

Production Engineering Marketing Research 52

Perficient: Drug Development

JANUARY 14, 2024

The Seven Principles of Universal Design: To understand the essence of Universal Design, let’s explore its seven guiding principles: Equitable Use: Design products and environments that are useful and marketable to people with diverse abilities. Stay tuned, and let’s shape a future where design knows no barriers!

Production 52

Production Marketing 52

Perficient: Drug Development

NOVEMBER 1, 2023

When it comes to web applications in the digital age, data is essential for making well-informed decisions, particularly when it comes to marketing and user engagement. An open-source browser extension called Omnibug is one such tool that makes it easier to debug and uncover requests made through the use of digital marketing techniques.

Marketing 52

Marketing 52

Perficient: Drug Development

JUNE 20, 2023

With an estimated 285 million visually impaired people worldwide, catering to their needs and preferences can lead to increased customer loyalty, positive brand reputation, and enhanced market reach.

Production 52

Production Marketing 52

Perficient: Drug Development

JANUARY 29, 2024

make your product accessible to your audience, contact our experienced design experts , check out our Accessibility IQ for your website, download our guide Digitally Accessible Experiences: Why It Matters and How to Create Them , and read more from our UX for Accessible Design series.

Production 52

Production Marketing 52

Perficient: Drug Development

JANUARY 28, 2024

make your product accessible to your audience, contact our experienced design experts, check out our Accessibility IQ for your website, download our guide Digitally Accessible Experiences: Why It Matters and How to Create Them , and read more from our UX for Accessible Design series.

Production 52

Production Marketing 52

Perficient: Drug Development

MARCH 21, 2024

make your product accessible to your audience, contact our experienced design experts , check out our Accessibility IQ for your website, download our guide Digitally Accessible Experiences: Why It Matters and How to Create Them , and read more from our UX for Accessible Design series.

Production 52

Production Marketing 52

Perficient: Drug Development

AUGUST 20, 2023

This post is an overview of a composable Sitecore Send offering – an email marketing automation solution with no code campaign automation. It aims to be a global leader in the market automation space, with accolades for usability and customer satisfaction. Later, you can also import a JSON file back into the editor.

Marketing 52

Marketing Regulations Production International 52

Perficient: Drug Development

MAY 9, 2024

make your product accessible to your audience, contact our experienced design experts , check out our Accessibility IQ for your website, download our guide Digitally Accessible Experiences: Why It Matters and How to Create Them , and read more from our UX for Accessible Design series.

Production 52

Production Regulations Marketing 52

Perficient: Drug Development

NOVEMBER 30, 2023

make your product accessible to your audience, contact our experienced design experts , check out our Accessibility IQ for your website, download our guide Digitally Accessible Experiences: Why It Matters and How to Create Them , and read more from our UX for Accessible Design series.

Production 52

Production Marketing 52

The Pharma Data

DECEMBER 14, 2020

The global GBM treatment market is projected to reach $3.3 representing the largest market. The ability of a drug candidate to cross the blood brain barrier is of critical importance in treatment outcomes for CNS and brain cancers. . billion by 2024, according to GlobalData, with the U.S.

Clinical Trials 52

Clinical Trials DNA Drugs Therapies 52